DDX11 antisense RNA 1 acts as a resistance catalyst by activating the Nrf2-Keap1 pathway in HCC to prevent sorafenib-triggered ferroptosis (78). The gene discussed is NFE2L2; the disease is hepatocellular carcinoma.